Literature DB >> 21847292

Primidone in epilepsy-its value in fresh and refractory cases.

R K Mahendru1, S Mahendru, R Chandra.   

Abstract

Entities:  

Year:  1983        PMID: 21847292      PMCID: PMC3012323     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


× No keyword cloud information.
  5 in total

1.  Mysoline; an effective anticonvulsant with initial problems of adjustment.

Authors:  W H TIMBERLAKE; J A ABBOTT; R S SCHWAB
Journal:  N Engl J Med       Date:  1955-02-24       Impact factor: 91.245

2.  Primidone in the treatment of non-idiopathic epilepsy.

Authors:  P W NATHAN
Journal:  Lancet       Date:  1954-01-02       Impact factor: 79.321

3.  Mysoline in the treatment of epilepsy.

Authors:  A J M BUTTER
Journal:  Lancet       Date:  1953-05-23       Impact factor: 79.321

4.  Clinical evaluation of primidone (Mysoline), new anticonvulsant drug.

Authors:  D SCIARRA; S CARTER; C T VICALE; H H MERRITT
Journal:  J Am Med Assoc       Date:  1954-03-06

5.  Primidone (mysoline) in the treatment of clinical petit mal in children.

Authors:  J N BRIGGS; J TUCKER
Journal:  Lancet       Date:  1954-01-02       Impact factor: 79.321

  5 in total
  1 in total

Review 1.  Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications.

Authors:  Fakher Rahim; Reza Azizimalamiri; Mehdi Sayyah; Alireza Malayeri
Journal:  J Exp Pharmacol       Date:  2021-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.